Search

Search Constraints

You searched for: Author/Creator Jürgenliemk-Schulz, Ina

Search Results

1. 2022-RA-568-ESGO Prognostic Relevance of FIGO grading is Limited to NSMP Endometrial Cancers. (20th October 2022)

2. 2022-RA-648-ESGO Interpretable deep learning provides clues for prognostic refinement of the molecular endometrial cancer classification. (20th October 2022)

3. 2022-RA-925-ESGO Development of adjuvant treatment decision support tool for endometrial cancer patients by pooled analysis of data from 2000 women included in the PORTEC-1–3 trials and a prospective cohort study. (20th October 2022)

4. 2022-RA-934-ESGO Vaginal changes, sexual functioning and distress of women with locally advanced cervical cancer treated in the EMBRACE vaginal morbidity sub-study. (20th October 2022)

5. Dose–volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study. Issue 3 (September 2016)

6. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer. Issue 3 (September 2016)

7. ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology. (June 2021)

8. H&N and Skin (HNS) GEC-ESTRO Working Group critical review of recommendations regarding prescription depth, bolus thickness and maximum dose in skin superficial brachytherapy with flaps and customized moulds. (October 2022)

9. Image Guided Adaptive Brachytherapy in cervix cancer: A new paradigm changing clinical practice and outcome. Issue 3 (September 2016)

10. Importance of training in external beam treatment planning for locally advanced cervix cancer: Report from the EMBRACE II dummy run. (April 2019)